InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,442.00
(
2.14%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
0.00%
)
Bitcoin
63,128.02
(
0.38%
)
Post# of 20617
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Honeycomb777

Send PM Follow Ignore
Followers 105
Posts 20514
Boards Moderated 1
Alias Born 06/30/2012

Honeycomb777

Re: None

Wednesday, 09/21/2016 7:27:38 PM

Wednesday, September 21, 2016 7:27:38 PM

Post# of 20617
Couple of important items folks:

- Well, the FDA is certainly under the gun with this whole Mylan EpiPen saga. Lots of blame to be passed around but the crux of the issue really is cost. Costs are definitely brought down when safe and effective generic medicines are approved quicker. The FDA controls that part/process folks.

To me, the more (bad) press for Mylan and the FDA - the better chance Fluticare gets approved any day now. Seriously, it is safe and effective - is it not?

- FWIW, there is a poster over on the Yahoo board that is claiming that his sources in Washington have confirmed to him that approval is coming very soon. Poster seems legit IMO
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up